Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Mineralys Therapeutics
MLYS
$2.25B
| $2.39M | ﹤0.01% |
176,926
-374
| -0.2% | -$5.42K |
|
2002
Rentokil
RTO
$11.8B
| $2.39M | ﹤0.01% |
+99,700
| New | +$2.31M |
|
2003
Seer Inc
SEER
$122M
| $2.39M | ﹤0.01% |
1,117,710
+291,704
| +35% | +$584K |
|
2004
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
| $2.39M | ﹤0.01% |
+18,100
| New | +$2.27M |
|
2005
Protalix BioTherapeutics
PLX
$191M
| $2.39M | ﹤0.01% |
1,615,003
+426,050
| +36% | +$872K |
|
|
ASM
2006
Avino Silver & Gold Mines
ASM
$934M
| $2.39M | ﹤0.01% |
663,500
+549,900
| +484% | +$1.48M |
|
2007
Radcom
RDCM
$171M
| $2.39M | ﹤0.01% |
175,733
-6,900
| -4% | -$84.4K |
|
2008
Nokia
NOK
$51B
| $2.38M | ﹤0.01% |
460,180
-3,206,200
| -87% | -$16.5M |
|
2009
Enovis
ENOV
$1.68B
| $2.38M | ﹤0.01% |
+75,967
| New | +$2.51M |
|
2010
Myriad Genetics
MYGN
$270M
| $2.38M | ﹤0.01% |
448,374
+198,600
| +80% | +$1.17M |
|
2011
Astrana Health
ASTH
$1.76B
| $2.38M | ﹤0.01% |
95,600
-93,100
| -49% | -$2.62M |
|
2012
Valens Semiconductor
VLN
$170M
| $2.37M | ﹤0.01% |
902,230
-28,970
| -3% | -$66.8K |
|
2013
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
| $2.36M | ﹤0.01% |
56,535
-48,661
| -46% | -$2M |
|
2014
Compugen
CGEN
$222M
| $2.36M | ﹤0.01% |
1,327,100
-68,172
| -5% | -$101K |
|
|
BTC
2015
Grayscale Bitcoin Mini Trust ETF
BTC
$3.33B
| $2.36M | ﹤0.01% |
49,360
+20,100
| +69% | +$878K |
|
2016
iShares Core US Aggregate Bond ETF
AGG
$137B
| $2.35M | ﹤0.01% |
+23,700
| New | +$2.32M |
|
|
KLC
2017
KinderCare Learning Companies
KLC
$634M
| $2.35M | ﹤0.01% |
232,300
+186,300
| +405% | +$2.15M |
|
2018
Invesco Total Return Bond ETF
GTO
$2.41B
| $2.34M | ﹤0.01% |
50,000
+19,900
| +66% | +$922K |
|
|
ZK
2019
DELISTED
Zeekr
ZK
| $2.34M | ﹤0.01% |
91,800
-190,385
| -67% | -$4.69M |
|
2020
Sprout Social
SPT
$516M
| $2.34M | ﹤0.01% |
+111,862
| New | +$2.37M |
|
2021
Valhi
VHI
$380M
| $2.32M | ﹤0.01% |
143,817
+3,200
| +2% | +$51.1K |
|
2022
Dimensional US Core Equity 2 ETF
DFAC
$47.9B
| $2.32M | ﹤0.01% |
64,800
+53,700
| +484% | +$1.79M |
|
2023
Structure Therapeutics
GPCR
$3.41B
| $2.32M | ﹤0.01% |
111,900
+96,100
| +608% | +$2.11M |
|
2024
Imperial Oil
IMO
$62.7B
| $2.32M | ﹤0.01% |
29,195
+17,995
| +161% | +$1.28M |
|
2025
Johnson Controls International
JCI
$88.8B
| $2.32M | ﹤0.01% |
21,944
-201,200
| -90% | -$18.5M |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.